Identification of phenothiazine derivatives and analogs by x-ray diffraction. II. Active substances in pharmaceutical formulations.
D000639:Amitriptyline / Q000032:analysis; D002749:Chlorprothixene / Q000032:analysis; D003460:Crystallization; D003984:Dibenzazepines / Q000032:analysis; D005476:Fluphenazine / Q000032:analysis; D007099:Imipramine / Q000032:analysis; D008722:Methods; D008728:Methotrimeprazine / Q000032:analysis; D009661:Nortriptyline; D009888:Opipramol / Q000032:analysis; D010546:Perphenazine / Q000032:analysis; D010640:Phenothiazines / Q000032:analysis*; D010851:Picrates; D011346:Prochlorperazine / Q000032:analysis; D011395:Promazine / Q000032:analysis; D011398:Promethazine / Q000032:analysis; D000644:Quaternary Ammonium Compounds; D013881:Thioridazine / Q000032:analysis; D014273:Triflupromazine / Q000032:analysis; D014961:X-Ray Diffraction
D003984:Dibenzazepines; D010640:Phenothiazines; D010851:Picrates; D000644:Quaternary Ammonium Compounds; D000639:Amitriptyline; D008728:Methotrimeprazine; D002749:Chlorprothixene; D009661:Nortriptyline; D009888:Opipramol; D011398:Promethazine; D010546:Perphenazine; D013881:Thioridazine; D011395:Promazine; D007099:Imipramine; D014273:Triflupromazine; D005476:Fluphenazine; D011346:Prochlorperazine